Jack Abraham
Chairman & Co-Founder @ Indomo
San Francisco, United States
Jack Abraham is a seed investor at Indomo in San Francisco focused on Health Care and Software. Jack Abraham is based out of Florida and is the Chairman and Co-Founder of Indomo. Jack previously worked at TalkIQ as a Co-Founder and Investor. Jack Abraham attended The Wharton School.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Jack Abraham invests in
Stages Jack Abraham invests in
Countries Jack Abraham invests in
Round sizes
Round size
- Seed
- $1.2M–$20M
- Series A
- $5M–$50M
- Series B
- $17M–$100M
Investment Focus
Industry
- Health Care 9 (24%)
- Software 6 (16%)
- Financial Services 5 (14%)
- Wellness 4 (11%)
- Biotechnology 4 (11%)
Stage
- Seed 20 (54%)
- Series A 9 (24%)
- Series B 4 (11%)
- Angel 1 (3%)
- Series E 1 (3%)
Country
- United States 26 (70%)
- France 1 (3%)
- Hong Kong 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Exowatt
|
Modular Full-Stack Renewable Energy Solutions for Commercial and Industrial Applications | $50M / Series A / Nov 13, 2025 | |
Arago
|
Arago develops a computing system that uses photonic technology to accelerate core operations in artificial intelligence and scientific computing. The company focuses on enhancing matrix multiplication performance, a key computational component in modern AI models, by using light-based processes rather than traditional electronic circuits. Itssystem integrates a PyTorch-based software stack with a multi-physics processor that handles tasks with cubic complexity, while a digital processor manages remaining operations with quadratic complexity. This hybrid approach maximizes memory transfer efficiency and processing capacity. The system supports industry-standard form factors, allowing for integration into existing hardware infrastructure without requiring significant changes. | $26M / Seed / Jul 08, 2025 | |
Healify
|
Healify is a mobile application that utilizes artificial intelligence to provide users with personalized health insights. The app collects data from various sources, such as wearable devices, biometric inputs, and lifestyle information, to offer tailored recommendations. Its features include tracking of sleep patterns, stress levels, and physicalactivity, aiming to assist users in managing their overall well-being. Healify also offers real-time guidance based on the user's health data, facilitating informed decisions about daily habits and routines. | $2M / Seed / May 01, 2025 | |
|
Exowatt
|
Modular Full-Stack Renewable Energy Solutions for Commercial and Industrial Applications | $35M / Series A / Apr 22, 2025 | |
Dorsia
|
Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities. The platform utilizes technology to enhance experiences for both operators and members, ensuring smooth booking without stress. Dorsia operates in various cities, including Miami, Los Angeles, Dubai, and San Francisco, making it a versatile choicefor food enthusiasts. | $50.4M / Series A / Feb 14, 2025 | |
Gameto
|
Gameto is a biotechnology company whose mission is to redefine female reproductive health by developing therapies that improve lives.Women’s health is a vastly underserved therapeutic area. Most conditions have few treatment options, and those available often cause frequent complications and offer limited clinical benefit. Gameto aims to changethat.Gameto is committed to using cutting-edge scientific advances to deliver better solutions to patients. Using cellular engineering, they have developed a platform to produce female reproductive cell lines. They use proprietary combinations of transcription factors to reprogram hiPSCs into engineered ovarian and endometrium cell lines that mimic the functions of endogenous cells, producing and responding to all hormones. Their team of cellular engineers is using this platform to advance a portfolio of cellular therapeutics for female reproductive diseases. Gameto's first program, Fertilo, is a therapeutic for IVF and egg freezing, aiming to make the process shorter, safer and more effective. Additional applications of our platform include, an organoid of the female reproductive system, Deovo, and a cell-based therapeutic to ameliorate the health consequences of primary ovarian insufficiency and menopause, Ameno. | $33M / Series B / May 29, 2024 | |
|
Exowatt
|
Modular Full-Stack Renewable Energy Solutions for Commercial and Industrial Applications | $20M / Seed / Apr 22, 2024 | |
Software Applications Incorporated
|
Rethinking the personal computing experience | $6.5M / Seed / Nov 30, 2023 | |
Dispatch
|
Dispatch helps independent financial advisors to build ideal firms through strategic investments and advanced technology. | $4.3M / Seed / Jul 10, 2023 | |
JustPaid
|
JustPaid is a financial platform that helps startups control their spending and gives them financial oversight. | $3.5M / Seed / Jun 27, 2023 | |
| See all 37 investments → | |||
Co-Investors
About Indomo
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
Indomo Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jack Abraham
Chairman & Co-Founder
|
|||
Rick Bente
CEO & Co-Founder
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Jack Abraham invest in?
Jack Abraham invests primarily in Health Care, Software and Financial Services startups, most often at Seed and Series A stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Jack Abraham's check size?
Jack Abraham typically joins rounds of $1.2M–$20M at Seed, $5M–$50M at Series A and $17M–$100M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Jack Abraham participates in.
When did Jack Abraham last invest?
The most recent investment recorded for Jack Abraham closed in Nov 2025. Shizune tracks 37 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
